Matthew G. Brown is Senior Director for Life Sciences Business Advisory at Wilson Sonsini Goodrich & Rosati. Based in San Diego, his practice focuses on advising early-stage life sciences companies with capital raises and strategic business development initiatives.

Matthew is an experienced executive and attorney who has held diverse roles of increasing responsibility across a wide range of private and public life sciences companies in the research tool, in vitro diagnostic, therapeutic, and therapeutic-enabling space including Genentech, Millipore Sigma, and Becton Dickinson & Company. His contributions span the continuum of strategic business development activities, from search and evaluation through alliance and program management.

Prior to joining the firm, Matthew led all aspects of commercialization and business development for Monod Bio, a privately held University of Washington Institute for Protein Design spin-out company focused on AI/ML-enabled de novo protein design to build next generation research tools and in vitro diagnostics. While at Monod, he consummated the company’s first revenue-generating research and in vitro diagnostic collaborations and commercial license agreements. Previously, Matthew led strategy, business development, and licensing for Exagen, Inc., a publicly traded rheumatology-focused diagnostics company, where he was instrumental in shepherding the company into the precision medicine diagnostics arena.